Related Experiment Video
Updated: Aug 25, 2025

Author Spotlight: Investigating the Effects of Compounds on Intestinal Tissue Using 3D Human Cell Line Models
Published on: September 1, 2023
Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity
Tom Breugelmans1,2, Wout Arras1,2, Lauren-Emma Boen1,2
1Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Mucin expression is altered in pediatric inflammatory bowel disease (IBD) patients, correlating with disease activity. This suggests mucins could serve as diagnostic and management markers for IBD.
Area of Science:
- Gastroenterology
- Molecular Biology
- Pediatric Medicine
Background:
- Inflammatory bowel disease (IBD) management lacks objective molecular markers for intestinal mucosal healing.
- Dysregulated mucin expression is implicated in IBD mucosal barrier dysfunction.
Purpose of the Study:
- Investigate mucin expression in pediatric IBD patients.
- Correlate mucin expression with barrier mediators and clinical characteristics.
Main Methods:
- Quantified mRNA expression of mucins and barrier-related genes in colonic biopsies from pediatric IBD and non-IBD patients.
- Validated mucin expression at the protein level.
- Correlated mRNA expression with clinical data and disease activity indices.
Main Results:
- Increased MUC1, MUC3A, MUC4, and MUC13 mRNA in inflamed pediatric IBD colons.
- MUC13 mRNA associated with barrier mediators (CDH1, OCLN, TJP2).
- MUC1 and MUC3B mRNA distinguished IBD patients (90.6% AUCROC).
- Aberrant mucin expression differed between ulcerative colitis and Crohn's disease.
- Mucin expression correlated with clinical disease activity and endoscopic severity.
Conclusions:
- Colonic mucin expression is disturbed in pediatric IBD.
- Mucin expression associates with IBD disease activity and presentation.
- Mucins show potential as molecular markers for IBD diagnosis and management.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

